“The objective of the study is to measure the epidemiology and drug use with patients affected by ITP. According to the study, ITP was equal to 262 cases / million assisted. About two thirds of the patients were treated with corticosteroid drugs and, among these, the majority had an exposure exceeding three months of therapy ”. This was stated by Luca Degli Esposti, President of CliCon Health, Economics and Outcomes Research, on the sidelines of the event “Primary Immune Thrombocytopenia: changing the approach to change your life”, promoted by Inrete with the non-conditioning contribution of Novartis.
!function(f,b,e,v,n,t,s)
{if(f.fbq)return;n=f.fbq=function(){n.callMethod?
n.callMethod.apply(n,arguments):n.queue.push(arguments)};
if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′;
n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];
s.parentNode.insertBefore(t,s)}(window, document,’script’,
‘https://connect.facebook.net/en_US/fbevents.js’);
fbq(‘init’, ‘415374439673532’);
fbq(‘track’, ‘PageView’);
Read Also
- The HAS recommends generalizing screening for sickle cell disease to all newborns Nov 15, 2022
- The mosques of France ready for the Aïd el-Kébir, the practical adaptations to the time of the Covid-19 Jul 30, 2020
- Balearics coronavirus figures for Saturday Jul 3, 2021
- The protections for skating, an essential May 30, 2021
- Horford enters health protocols and will not play tonight May 19, 2022
- Brentford achieves promotion to Premier League after 74 years May 30, 2021
- China has built a second hospital for patients with coronavirus Feb 8, 2020
